Circulation. 2005;111:3255-3260
Published online before print June 13, 2005,
doi: 10.1161/CIRCULATIONAHA.104.485029
(Circulation. 2005;111:3255-3260.)
© 2005 American Heart Association, Inc.
Noninvasive Imaging of Angiogenesis With a 99mTc-Labeled Peptide Targeted at
vß3 Integrin After Murine Hindlimb Ischemia
Jing Hua, MD*;
Lawrence W. Dobrucki, PhD*;
Mehran M. Sadeghi, MD;
Jiasheng Zhang, MD;
Brian N. Bourke, MS;
Patti Cavaliere, BS;
James Song, MD;
Conroy Chow;
Neda Jahanshad;
Niels van Royen, MD, PhD;
Ivo Buschmann, MD;
Joseph A. Madri, MD, PhD;
Marivi Mendizabal, PhD;
Albert J. Sinusas, MD
From the Section of Cardiovascular Medicine, Department of Internal Medicine (J.H., L.W.D., M.M.S., J.Z., B.N.B., P.C., J.S., C.C., N.J., A.J.S.), and Department of Pathology (J.A.M.), Yale University School of Medicine, New Haven, Conn; Department of Internal Medicine III, Albert-Ludwigs University, Freiburg, Germany (J.H., N.v.R., I.B.); VA Connecticut Healthcare System, West Haven, Conn (M.M.S., J.Z.); and GE Healthcare, Buckinghamshire, UK (M.M.).
Correspondence to Albert J. Sinusas, MD, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, PO Box 208017, 3FMP, New Haven, CT 06520-8017. E-mail albert.sinusas{at}yale.edu
Received June 17, 2004; revision received February 4, 2005; accepted February 16, 2005.
Background Noninvasive imaging strategies play a critical role in assessment of the efficacy of angiogenesis therapies. The
vß3 integrin is activated in angiogenic vessels and represents a potential target for noninvasive imaging of angiogenesis.
Methods and Results We evaluated a 99mTc-labeled peptide (NC100692) targeted at
vß3 integrin for imaging in an established murine model of angiogenesis induced by hindlimb ischemia. Control mice (n=9) or mice with surgical right femoral artery occlusion (n=29) were injected with NC100692 (1.5±0.2 mCi IV) at different times after femoral occlusion (1, 3, 7, and 14 days) for in vivo pinhole planar gamma camera imaging. Tissue from hindlimb proximal and distal to occlusion was excised for gamma well counting and for immunostaining. On in vivo pinhole images, increased focal NC100692 activity was seen distal to the occlusion at days 3 and 7. This increase in relative NC100692 activity was confirmed by gamma well counting. Lectin staining confirmed increased angiogenesis in the ischemic hindlimb at these time points. A fluorescent analogue of NC100692 was used to confirm specificity and localization of the targeted tracer in cultured endothelial cells. In addition, endothelial cell specificity was confirmed on tissue sections with the use of dual immunofluorescent staining of endothelium and the fluorescent analogue targeted at the
vß3 integrin.
Conclusions A 99mTc-labeled peptide (NC100692) targeted at
vß3 integrin selectively localized to endothelial cells in regions of increased angiogenesis and could be used for noninvasive serial "hot spot" imaging of angiogenesis. This targeted radiotracer imaging approach is a major advance in tracking therapeutic myocardial angiogenesis and has an important clinical potential.
Key Words: angiogenesis imaging ischemia radioisotopes
Related Article:
-
Molecular Images of Neovascularization: Art for Arts Sake or Form With a Function?
- Flordeliza S. Villanueva
Circulation 2005 111: 3188-3191.
[Extract]
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
T. J. Wadas, H. Deng, J. E. Sprague, A. Zheleznyak, K. N. Weilbaecher, and C. J. Anderson
Targeting the {alpha}v{beta}3 Integrin for Small-Animal PET/CT of Osteolytic Bone Metastases
J. Nucl. Med.,
November 1, 2009;
50(11):
1873 - 1880.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Matter, M. Stuber, and M. Nahrendorf
Imaging of the unstable plaque: how far have we got?
Eur. Heart J.,
November 1, 2009;
30(21):
2566 - 2574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Leong-Poi
Molecular imaging using contrast-enhanced ultrasound: evaluation of angiogenesis and cell therapy
Cardiovasc Res,
November 1, 2009;
84(2):
190 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Morooka, K. Kubota, H. Kadowaki, K. Ito, O. Okazaki, M. Kashida, T. Mitsumoto, R. Iwata, K. Ohtomo, and M. Hiroe
11C-Methionine PET of Acute Myocardial Infarction
J. Nucl. Med.,
August 1, 2009;
50(8):
1283 - 1287.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. W. Dobrucki, D. P. Dione, L. Kalinowski, D. Dione, M. Mendizabal, J. Yu, X. Papademetris, W. C. Sessa, and A. J. Sinusas
Serial Noninvasive Targeted Imaging of Peripheral Angiogenesis: Validation and Application of a Semiautomated Quantitative Approach
J. Nucl. Med.,
August 1, 2009;
50(8):
1356 - 1363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Almutairi, R. Rossin, M. Shokeen, A. Hagooly, A. Ananth, B. Capoccia, S. Guillaudeu, D. Abendschein, C. J. Anderson, M. J. Welch, et al.
Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis
PNAS,
January 20, 2009;
106(3):
685 - 690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nahrendorf, D. E. Sosnovik, B. A. French, F. K. Swirski, F. Bengel, M. M. Sadeghi, J. R. Lindner, J. C. Wu, D. L. Kraitchman, Z. A. Fayad, et al.
Multimodality Cardiovascular Molecular Imaging, Part II
Circ Cardiovasc Imaging,
January 1, 2009;
2(1):
56 - 70.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Sinusas, F. Bengel, M. Nahrendorf, F. H. Epstein, J. C. Wu, F. S. Villanueva, Z. A. Fayad, and R. J. Gropler
Multimodality Cardiovascular Molecular Imaging, Part I
Circ Cardiovasc Imaging,
November 1, 2008;
1(3):
244 - 256.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Franc, P. D. Acton, C. Mari, and B. H. Hasegawa
Small-Animal SPECT and SPECT/CT: Important Tools for Preclinical Investigation
J. Nucl. Med.,
October 1, 2008;
49(10):
1651 - 1663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. F. Langer, R. Haubner, B. J. Pichler, and M. Gawaz
Radionuclide imaging a molecular key to the atherosclerotic plaque.
J. Am. Coll. Cardiol.,
July 1, 2008;
52(1):
1 - 12.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Sinusas
Targeted imaging offers advantages over physiological imaging for evaluation of angiogenic therapy.
J. Am. Coll. Cardiol. Img.,
July 1, 2008;
1(4):
511 - 514.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Higuchi, F. M. Bengel, S. Seidl, P. Watzlowik, H. Kessler, R. Hegenloh, S. Reder, S. G. Nekolla, H. J. Wester, and M. Schwaiger
Assessment of {alpha}v{beta}3 integrin expression after myocardial infarction by positron emission tomography
Cardiovasc Res,
May 1, 2008;
78(2):
395 - 403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Willmann, K. Chen, H. Wang, R. Paulmurugan, M. Rollins, W. Cai, D. S. Wang, I. Y. Chen, O. Gheysens, M. Rodriguez-Porcel, et al.
Monitoring of the Biological Response to Murine Hindlimb Ischemia With 64Cu-Labeled Vascular Endothelial Growth Factor-121 Positron Emission Tomography
Circulation,
February 19, 2008;
117(7):
915 - 922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. L. Johnson, L. Schofield, T. Donahay, M. Bouchard, A. Poppas, and R. Haubner
Radiolabeled RGD Peptides to Image Angiogenesis in Swine Model of Hibernating Myocardium.
J. Am. Coll. Cardiol. Img.,
January 1, 2008;
1:
500 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zennadi, B. J. Moeller, E. J. Whalen, M. Batchvarova, K. Xu, S. Shan, M. Delahunty, M. W. Dewhirst, and M. J. Telen
Epinephrine-induced activation of LW-mediated sickle cell adhesion and vaso-occlusion in vivo
Blood,
October 1, 2007;
110(7):
2708 - 2717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bach-Gansmo, R. Danielsson, A. Saracco, B. Wilczek, T. V. Bogsrud, A. Fangberget, A. Tangerud, and D. Tobin
Integrin Receptor Imaging of Breast Cancer: A Proof-of-Concept Study to Evaluate 99mTc-NC100692
J. Nucl. Med.,
September 1, 2006;
47(9):
1434 - 1439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J. Suuronen, J. P. Veinot, S. Wong, V. Kapila, J. Price, M. Griffith, T. G. Mesana, and M. Ruel
Tissue-Engineered Injectable Collagen-Based Matrices for Improved Cell Delivery and Vascularization of Ischemic Tissue Using CD133+ Progenitors Expanded From the Peripheral Blood
Circulation,
July 4, 2006;
114(1_suppl):
I-138 - I-144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. A. Jaffer, P. Libby, and R. Weissleder
Molecular and Cellular Imaging of Atherosclerosis: Emerging Applications
J. Am. Coll. Cardiol.,
April 4, 2006;
47(7):
1328 - 1338.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Lindsey, G. P. Escobar, L. W. Dobrucki, D. K. Goshorn, S. Bouges, J. T. Mingoia, D. M. McClister Jr., H. Su, J. Gannon, C. MacGillivray, et al.
Matrix metalloproteinase-9 gene deletion facilitates angiogenesis after myocardial infarction
Am J Physiol Heart Circ Physiol,
January 1, 2006;
290(1):
H232 - H239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. S. Villanueva
Molecular Images of Neovascularization: Art for Art's Sake or Form With a Function?
Circulation,
June 21, 2005;
111(24):
3188 - 3191.
[Full Text]
[PDF]
|
 |
|